Literature DB >> 24833035

Quinoid glycosides from Forsythia suspensa.

Chang Li1, Yi Dai2, Shu-Xiang Zhang3, Ying-Hui Duan2, Ming-Li Liu2, Liu-Yuan Chen2, Xin-Sheng Yao4.   

Abstract

Phytochemical investigation on Forsythia suspensa (Thunb.) Vahl afforded 10 compounds, including quinoid glycosides, lignan glycosides, phenylethanoid glycoside and allylbenzene glycoside together with 13 known ones. Their structures were established based on extensive spectroscopic data analyses, including IR, UV, HRESIMS, 1D NMR and 2D NMR. Absolute configurations were determined by ECD calculation method and chemical degradation. In addition, all compounds were evaluated for their antiviral activity against influenza A (H1N1) virus and several were further evaluated against respiratory syncytial virus (RSV) in vitro. Among them, two previously known compounds showed significant activities against RSV with EC50 values of 3.43 and 6.72 μM.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiviral activity; Forsythia suspensa; Lignan glycosides; Quinoid glycosides

Mesh:

Substances:

Year:  2014        PMID: 24833035     DOI: 10.1016/j.phytochem.2014.04.010

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  3 in total

Review 1.  Forsythiae Fructus: A Review on its Phytochemistry, Quality Control, Pharmacology and Pharmacokinetics.

Authors:  Zhanglu Dong; Xianyuan Lu; Xueli Tong; Yaqian Dong; Lan Tang; Menghua Liu
Journal:  Molecules       Date:  2017-09-04       Impact factor: 4.411

Review 2.  Antivirals for Respiratory Viral Infections: Problems and Prospects.

Authors:  Qiang Liu; Yuan-Hong Zhou; Feng Ye; Zhan-Qiu Yang
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

Review 3.  Plant-derived lignans as potential antiviral agents: a systematic review.

Authors:  Xin-Ya Xu; Dong-Ying Wang; Yi-Ping Li; Stephen T Deyrup; Hong-Jie Zhang
Journal:  Phytochem Rev       Date:  2021-05-31       Impact factor: 7.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.